Skip to Content

Vaccines, Volume 14, Issue 9

2026 September - 112 articles

Cover Story: Cancer vaccination has four clinical goals: preventing oncogenic infection, intercepting premalignant clones, clearing molecular residual disease, and treating established cancer. In this Review, we propose an antigen-defined, HLA-restricted T-cell vaccine framework organized around seven gates: tumor specificity, natural peptide-HLA presentation, population coverage, persistence under immune selection, selective T-cell recognition, manufacturability, and randomized clinical benefit. It combines a pre-manufactured core of validated shared antigens with a personalized shell when shared targets do not cover the tumor or the patient’s HLA type. Presentation-first selection and rigorous validation provide a practical research agenda for more effective and broadly applicable cancer vaccines. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (112)

  • Article
  • Open Access
447 Views
13 Pages

Measles Seroprotection and Catch-Up Vaccination in Medical Students and Other Healthcare Workers at a Large Teaching Hospital: Positive Impact of Mandatory Italian Vaccination Policies

  • Cristiana Ferrari,
  • Francesco Cama,
  • Lavinia Ponzo,
  • Ilenia Mazzocchi and ,
  • Claudia Salvi,
  • Lorenzo Ippoliti,
  • Andrea Magrini and
  • Luca Coppeta
  • + 3 authors+ 0 author

21 September 2026

Background: Measles resurgence across Europe has renewed attention to immunity gaps in healthcare environments. Following decades of sub-optimal coverage, Italy implemented mandatory vaccination under Law 119/2017 to counteract declining rates. Howev...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
431 Views
17 Pages

Knowledge of Herpes Zoster and Attitudes Toward Vaccination: A Questionnaire-Based Study in Outpatient and Online Settings

  • Michał Oleszko,
  • Artur Mazur,
  • Lech Zaręba,
  • Nikola Król and ,
  • Aleksandra Łoś and
  • Hanna Czajka
  • + 1 author+ 0 author

21 September 2026

Background/Objectives: Herpes zoster (HZ) vaccination rates remain low globally despite the availability of effective recombinant vaccines. This study aimed to assess knowledge of HZ and HZ vaccination, willingness to vaccinate, and factors associate...

(This article belongs to the Special Issue Acceptance and Hesitancy in Vaccine Uptake: 3rd Edition)
  • Article
  • Open Access
558 Views
18 Pages

mRNA Vaccines Targeting the Conserved SARS-CoV-2 Fusion Machinery Elicit Cross-Variant and Robust Immunity

  • Jun Li,
  • Ke-Meng Li,
  • Shu-Heng Yu,
  • Ming-Hua Li and ,
  • Xiao-Li Feng,
  • Wei Pang,
  • Yong-Tang Zheng and
  • Jian Zhang
  • + 3 authors+ 0 author

21 September 2026

Background/Objectives: Despite the gradual waning of global interest in SARS-CoV-2, the continued evolution and emergence of viral variants underscore the need for broadly protective vaccines. Vaccines targeting the highly mutable S1 subunit of the s...

(This article belongs to the Special Issue COVID-19 Vaccines in the Post-Pandemic Era: Immune Responses, Boosting Strategies, and Long-Term Outcomes)
  • Article
  • Open Access
400 Views
12 Pages

Low Match Between the Emerging ‘Mayotte-like’ Strain and the 919-Strain Bovine Ephemeral Fever Vaccine

  • Natalia Golender,
  • Dan Gleser,
  • Gabriel Kenigswald,
  • Shani Scheinin and
  • Eyal Klement

21 September 2026

Background/Objectives: Bovine ephemeral fever virus (BEFV) causes an economically important arthropod-borne cattle disease. In 2023, a lineage I “Mayotte-like” (ML) strain emerged in Israel during an outbreak in vaccinated herds, raising...

(This article belongs to the Special Issue Immunization Strategies for Animal Health: 2nd Edition)
  • Article
  • Open Access
498 Views
23 Pages

Timing-Dependent Immunostimulatory Activity of Human IFN-β mRNA in Primary Human Myeloid Cells

  • Silvia Fraude-El Ghazi,
  • Maria José Limeres,
  • Rocio Gambaro,
  • Ana Pena Vaquero and ,
  • Dirk Prawitt,
  • German Islan,
  • Stephan Gehring and
  • Maximiliano L. Cacicedo
  • + 3 authors+ 0 author

20 September 2026

Background/Objectives: Systemic administration of recombinant cytokines for immunomodulation in cancer and chronic infection is limited by toxicity and poor spatial control. Messenger RNA (mRNA)-encoded cytokines offer a programmable alternative, but...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Systematic Review
  • Open Access
425 Views
13 Pages

New-Onset Pemphigus Following Drug Exposure and Vaccination: A Systematic Review of Reported Cases

  • Gabriele Poddine,
  • Francesco Bellinato,
  • Paolo Gisondi and
  • Giampiero Girolomoni

20 September 2026

Background: Although an increasing number of cases of new-onset pemphigus have been reported following drug exposure or vaccination, the available evidence remains fragmented and distinguishing true trigger-associated disease from coincidental onset...

(This article belongs to the Special Issue Immune Responses in Patients with Chronic Disease After Vaccination)
  • Article
  • Open Access
511 Views
18 Pages

Preclinical Evaluation of a Microneedle-Delivered Adjuvanted Microparticulate Gonorrhea Vaccine in Non-Human Primates

  • Amarae Ferguson,
  • Yashkumar Harsoda,
  • Dedeepya Pasupuleti,
  • Tanisha Manoj Arte and ,
  • Priyal Bagwe,
  • Mahek Gulani,
  • Emmanuel Adediran,
  • Mohammad Uddin,
  • Nikolai Petrovsky and
  • Susu M. Zughaier
  • + 6 authors+ 1 author

20 September 2026

Background/Objectives: Gonorrhea remains one of the most prevalent sexually transmitted infections globally, with an estimated 82–87 million new infections annually and no licensed vaccine available. Antigenic variability and the lack of durabl...

(This article belongs to the Special Issue Biotechnologies Applied in Vaccine Research: 2nd Edition)
  • Systematic Review
  • Open Access
801 Views
16 Pages

20 September 2026

Background/Objectives: Adults eligible for respiratory syncytial virus (RSV) vaccination may also receive influenza, COVID-19, pneumococcal, or herpes zoster vaccines. We compared immunogenicity and safety between coadministration and sequential sche...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Review
  • Open Access
476 Views
14 Pages

Rethinking Candida Vaccine Translation: Barriers, Immunotherapies and a One Health Imperative

  • Julie Krier,
  • Francisco A. M. Silva and
  • Célia Fortuna Rodrigues

19 September 2026

Over the past decade, antifungal vaccinology has produced genuine proof of concept: adhesin-based candidates such as NDV-3A have completed Phase II human trials, and reverse-vaccinology pipelines now routinely generate multi-epitope constructs with h...

(This article belongs to the Special Issue Antibodies in Autoimmune, Chronic, and Infectious Diseases: Pathogenic Mechanisms, Biomarkers, and Vaccine Development)
  • Systematic Review
  • Open Access
760 Views
24 Pages

Efficacy and Response of R21/Matrix-M in Malaria Vaccine: A Systematic Review and Meta-Analysis of Clinical Trials

  • Aneeq Ur Rehman,
  • Victory Nnaemeka,
  • Muhammad Hassan Nasir,
  • Nurul Alia Azizan and ,
  • Ahmed M. Salman and
  • Ahmad Syibli Othman
  • + 1 author+ 0 author

19 September 2026

Background: R21/Matrix-M is a pre-erythrocytic malaria vaccine supported by a growing body of field-efficacy, immunogenicity, safety, controlled-challenge, and implementation evidence. We synthesized the contemporary human evidence and quantified pro...

(This article belongs to the Section Vaccines Against Tropical and Other Infectious Diseases)
  • Article
  • Open Access
645 Views
17 Pages

Structured Pharmacist-Led Vaccine Recommendation and Coadministration in Community Pharmacies: Real-World Evidence from Poland

  • Ewa Kuczwalska,
  • Anna Maria Dworakowska,
  • Magdalena Skarżyńska and
  • Magdalena Bujalska-Zadrożny

19 September 2026

Background and Objectives: Community pharmacies in Poland administer an expanding range of adult vaccines, including influenza, COVID-19, respiratory syncytial virus (RSV), herpes zoster and pneumococcal vaccines. While pharmacist vaccination service...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
624 Views
18 Pages

Does Neoplastic Disease Negatively Affect Serum Antibody Titers Against Core Vaccines in Dogs?

  • Paola Dall’Ara,
  • Claudia Pollera,
  • Daniela Invernizzi,
  • Sara Tomassone and
  • Joel Filipe

18 September 2026

Background/Objectives: Neoplasia currently represents the primary cause of death in companion animals worldwide, with one in four dogs developing a tumor during their lifetime. In this scenario, evaluating the immune status against core vaccine-preve...

(This article belongs to the Special Issue Animal Immunity and Veterinary Vaccine)
  • Article
  • Open Access
397 Views
17 Pages

Nucleos(t)ide Analog–Therapeutic Vaccination Switch: A Novel Approach for Safe and Effective Treatment Discontinuation in HBeAg (-) Chronic Hepatitis B Patients

  • Sheikh Mohammad Fazle Akbar,
  • Mamun Al Mahtab,
  • Mohammad Abdur Rahim,
  • Sheikh Mohammad Noor-E-Alam and ,
  • Musarrat Mahtab,
  • Ahmed Lutful Moben,
  • Rokshana Begum,
  • Dulal Chandra Das,
  • Gerardo Guillen and
  • Julio Cesar Aguilar
  • + 9 authors+ 4 authors

18 September 2026

Background/Objective: Long-term nucleos(t)ide analog (NUC) therapy effectively suppresses hepatitis B virus (HBV) replication, but it rarely achieves a functional cure and typically requires lifelong administration. A major unmet need in chronic hepa...

(This article belongs to the Section Hepatitis Virus Vaccines)
  • Article
  • Open Access
383 Views
12 Pages

The Attitude–Uptake Gap in HPV Vaccination Among Adults Aged 18–45 Years in Poland: Sociodemographic and Psychosocial Correlates

  • Klaudiusz Mankiewicz,
  • Mikołaj Wachowski,
  • Julia Kłos,
  • Stanisław Klamecki-Cichy and
  • Hanna Krauss

18 September 2026

Background: Favorable attitudes toward human papillomavirus (HPV) vaccination do not necessarily translate into vaccine uptake, particularly among young adults who were too old to benefit from recently expanded adolescent programs. We assessed the ga...

(This article belongs to the Special Issue Acceptance and Hesitancy in Vaccine Uptake: 3rd Edition)
  • Article
  • Open Access
372 Views
29 Pages

Trust, Access, and the Division of Responsibility for Vaccine Confidence in Central and Eastern Europe: Paired Own-Country and Regional Ratings from a Multi-Stakeholder Professional Panel

  • Teodor Cristian Blidaru,
  • Alexandru Rafila,
  • Diana Nastasă,
  • David Sinclair and ,
  • Petr Smejkal,
  • Yasmin Maor,
  • Ernest Kuchar,
  • Mariano Votta,
  • Luminița Vâlcea and
  • Valeriu Gheorghiță
  • + 5 authors+ 0 author

17 September 2026

Background/Objectives: Immunisation coverage gaps in Central and Eastern Europe (CEE) are commonly attributed to barriers of access. This study measured how the professionals who deliver immunisation services weigh competing barriers, whether their a...

(This article belongs to the Special Issue Acceptance and Hesitancy in Vaccine Uptake: 3rd Edition)
  • Case Report
  • Open Access
699 Views
14 Pages

17 September 2026

Canine leishmaniasis (CanL), caused by Leishmania infantum, can be difficult to manage in dogs with severe clinical disease, particularly when established treatments are impractical or poorly tolerated. We report an approximately 3-year-old mixed-bre...

(This article belongs to the Special Issue Animal Immunity and Veterinary Vaccine)
  • Article
  • Open Access
546 Views
15 Pages

17 September 2026

Background/Objectives: Ongoing measles outbreaks in Canada and worldwide, largely among unvaccinated individuals, emphasize the importance of examining predictors of measles vaccination. This study aims to report on factors associated with up-to-date...

(This article belongs to the Special Issue Pediatric Infectious Diseases and Immunization)
  • Article
  • Open Access
571 Views
33 Pages

The Silent Vehicle: Validating the Biological Signals and Noises of Baculovirus Vectors in Macrophage-Targeted Vaccines

  • Beginda Ridwan,
  • Farrah Putri Salmanida,
  • Rika Wahyuningtyas,
  • Yin-Siew Lai and ,
  • Mei-Li Wu,
  • Wen-Bin Chung,
  • Chia-Tsai Chang and
  • Ko-Tung Chang
  • + 3 authors+ 0 author

16 September 2026

Objective: The Baculovirus Expression Vector System (BEVS) is an established eukaryotic platform for high-yield recombinant protein production and is widely utilized for generating vaccine antigens, including recombinant classical swine fever virus E...

(This article belongs to the Special Issue Challenges to Developing New Vaccines and Improving Existing Platforms)
  • Conference Report
  • Open Access
648 Views
11 Pages

Rotavirus Vaccines at 20 Years: Success, Challenges, and the Road Ahead

  • Alice S. Carter,
  • Duncan Steele,
  • Mathuram Santosham,
  • Michelle J. Groome and
  • Denise O. Garrett

16 September 2026

Twenty years after the introduction of rotavirus vaccines, the 15th International Rotavirus Symposium convened researchers, clinicians, immunization program managers, and policymakers to review advances in rotavirus epidemiology, immunology, vaccine...

(This article belongs to the Special Issue The Surveillance and Longterm Impact of Rotavirus Vaccines and Associated Infections in Africa)
  • Article
  • Open Access
445 Views
12 Pages

A Recombinant RABV-G-Based Chemiluminescence Immunoassay for Quantitative Detection of Rabies Virus Antibodies

  • Yan Zhang,
  • Lei Wang,
  • Yanan Han,
  • Na Feng and ,
  • Ye Feng and
  • Weiyao Sun
  • + 1 author+ 0 author

16 September 2026

Background: Rabies is a nearly 100% fatal zoonosis, and a rabies virus-neutralizing antibody (RVNA) titre of ≥0.5 IU/mL is the recognized correlate of protection, making post-vaccination serological monitoring essential. However, the gold-standard...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
331 Views
14 Pages

Cellular and Humoral Immune Responses in Anti-N Seropositive and Seronegative Vaccinated Participants: Insights from the Bialystok PLUS Study

  • Gabriela Trojan,
  • Anna Moniuszko-Malinowska,
  • Justyna Adamczuk,
  • Anna Citko-Rojewska and ,
  • Maciej Alimowski,
  • Piotr Czupryna,
  • Kiara Sequeira,
  • Hami Nguyen,
  • Justyna Dunaj-Małyszko and
  • Karol Adam Kamiński
  • + 14 authors+ 9 authors

16 September 2026

Background: In the post-pandemic era, SARS-CoV-2 immunity is increasingly shaped by vaccination and previous infection. Understanding the relationship between cellular and humoral immune responses is important for characterizing immunity in vaccinate...

(This article belongs to the Special Issue COVID-19 Vaccines in the Post-Pandemic Era: Immune Responses, Boosting Strategies, and Long-Term Outcomes)
  • Review
  • Open Access
386 Views
32 Pages

15 September 2026

SARS-CoV-2 infection after vaccination remains a clinical and public-health challenge because protection against infection may vary with time since vaccination, host factors, previous infection, and ongoing viral evolution. Although vaccination subst...

(This article belongs to the Special Issue Next-Generation SARS-CoV-2 Vaccines: Platforms, Evaluation, and Future Directions)
  • Review
  • Open Access
826 Views
21 Pages

Antigen 85B of Mycobacterium tuberculosis: From Immunodominant Antigen to Vaccine Candidate

  • Vivek Chauhan,
  • Gaytri Mahajan,
  • Rakesh Kumar,
  • Shrikanth S. Gadad and ,
  • Subhash C. Chauhan,
  • Chinnaswamy Jagannath and
  • Subramanian Dhandayuthapani
  • + 2 authors+ 0 author

15 September 2026

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), continues to pose a significant global health challenge despite the existence of effective treatments. The only licensed TB vaccine, Bacillus Calmette–Guérin (BCG), offers in...

(This article belongs to the Special Issue Vaccines for Tuberculosis Control)
  • Article
  • Open Access
392 Views
9 Pages

Influenza Vaccination Status and Clinical Outcomes Among Adults Hospitalized with Community-Acquired Pneumonia: A Retrospective Cohort from Saudi Arabia

  • Shouq M. Alzaaqi,
  • Ayman Banjar,
  • Majed A. Almoghrabi,
  • Seham F. Basheer and ,
  • Sami Alsaedi,
  • Saeed M. Algarni,
  • Ezzuddin A. Okmi,
  • Sarah A. Barzanji,
  • Samah A. Bukhari and
  • Haytham A. Sheerah
  • + 8 authors+ 3 authors

14 September 2026

Background: Influenza vaccination is widely recommended to prevent influenza and its complications; however, its association with clinical outcomes among high-risk populations remains uncertain. This study aimed to investigate the association between...

(This article belongs to the Special Issue The Effectiveness of Influenza Vaccine)
  • Article
  • Open Access
425 Views
14 Pages

Immunogenicity and Safety of a Single Booster Dose of Sabin-Strain Inactivated Poliovirus Vaccine in Adolescents and Adults: A Phase IV, Open-Label Trial

  • Xiaoshu Zhang,
  • Weixiao Han,
  • Jianfeng Wang,
  • Yu Tang and ,
  • Yanan Ji,
  • Liping Lu,
  • Junxia Zuo,
  • Yijing Nie,
  • Yajing Yao and
  • Jing An
  • + 7 authors+ 2 authors

14 September 2026

Background: In China, the current national immunisation schedule extends only to 4 years of age, and no polio booster dose is recommended for adolescents or adults, with data on immunogenicity and safety in these populations lacking. This phase IV tr...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
357 Views
13 Pages

Preparing for Future Group B Streptococcus Vaccines: Perspectives of Pregnant Women in Australia

  • Prabha H. Andraweera,
  • Emma Jeffs,
  • Bing Wang and
  • Helen S. Marshall

14 September 2026

Background: Vaccines for Group B Streptococcus (GBS) intended for pregnant women are currently in advanced stages of clinical trials. Conducting preparatory research now can help identify factors influencing GBS vaccine acceptance and potential chall...

(This article belongs to the Special Issue Maternal and Infant Vaccines)
  • Article
  • Open Access
495 Views
10 Pages

Analysis of Clinical Characteristics of Pertussis in Children Aged 0–6 Years in Tertiary and Pediatric Hospitals of Jiangsu Province from January to May 2024

  • Yan Xu,
  • Mei Li,
  • Qiang Chen,
  • Chengmei Jia and ,
  • Lingyan Tang,
  • Yuanbao Liu,
  • Zhiguo Wang and
  • Xiang Huo
  • + 3 authors+ 0 author

14 September 2026

Objective: To analyze the clinical manifestations and hospitalization-related factors among children with pertussis, and to provide scientific support for pertussis prevention, control, clinical diagnosis, and treatment. Methods: From January through...

(This article belongs to the Special Issue Diphtheria-Tetanus-Pertussis (DTP) Vaccination Strategy)
  • Review
  • Open Access
1,045 Views
29 Pages

Stepwise Evolution of Immunodeficient Mouse Models: Focus on NCG Strains and Their Applications in Humanized Immune System Research

  • Hongyan Sun,
  • Jialu Fan,
  • Yujing Zhang,
  • Jun Xing and ,
  • Yinlian Zhang,
  • Cunxiang Ju and
  • Juan Liang
  • + 2 authors+ 0 author

13 September 2026

Immunodeficient and humanized mouse models have become essential tools for investigating human immunity, disease pathogenesis, and therapeutic evaluation. This review summarizes the stepwise evolution of these platforms, from nude and SCID mice to ad...

(This article belongs to the Special Issue Genetically Engineered Mouse Models in Vaccine Development)
  • Article
  • Open Access
497 Views
13 Pages

Clinical and Public Health Lessons from a Point-Source Polymicrobial Foodborne Outbreak: Implications for Vaccination of Vulnerable Populations

  • Caterina Elisabetta Rizzo,
  • Davide Anzà,
  • Cristina Genovese,
  • Dalila Sciacca and ,
  • Salvatore Scondotto,
  • Antonio Cristaldi and
  • Vincenzo Restivo
  • + 2 authors+ 0 author

12 September 2026

Background: Foodborne outbreaks remain a major public health concern, particularly for immunocompromised individuals who experience a disproportionate burden of severe enteric disease. Although environmental prevention represents the cornerstone of f...

(This article belongs to the Special Issue Enteroviruses: Advances in Virology, Pathogenesis, and Vaccine R&D)
  • Review
  • Open Access
941 Views
26 Pages

11 September 2026

Background/Objectives: Vaccination represents one of the most significant achievements of modern medicine and public health. However, the scope, mandatory status, and vaccination coverage vary considerably across European countries. Methods: This nar...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
530 Views
12 Pages

Comparative Efficacy of Intramuscular and Intradermal Porcilis Lawsonia® Administration Under a Laboratory Challenge Model and Korean Field Conditions

  • Sungseok Lee,
  • Jincheol Kim,
  • Sohyun Seok,
  • Sangwon Lee and ,
  • Sunsook Hwang,
  • Jinyoung Hwang,
  • Leonardo Domingo Ellerma and
  • Chang-Seon Song
  • + 3 authors+ 0 author

11 September 2026

Background/Objectives: Lawsonia intracellularis is a major enteric pathogen of swine that causes proliferative enteropathy, reduced growth performance, and economic losses. Although vaccination is an effective control strategy, comparative data on th...

(This article belongs to the Special Issue Bacterial Vaccines in Veterinary Science)
  • Article
  • Open Access
501 Views
14 Pages

Association of Healthcare Professionals’ Characteristics and ZIP-Code-Level Income of Their Practice Location with Routine Assessment of HPV Vaccination Status

  • Olajumoke Ope Oladoyin,
  • Paula M. Cuccaro,
  • Lara S. Savas,
  • Robert Yu and ,
  • Sheryl McCurdy,
  • Monalisa Chandra,
  • Joel Fokom Domgue and
  • Sanjay Shete
  • + 3 authors+ 0 author

11 September 2026

Background: Although the human papillomavirus (HPV) vaccine has the potential to prevent most HPV-related cancers, its uptake in Texas remains lower than the national uptake and the Healthy People 2030’s goal of 80% completion among adolescents...

(This article belongs to the Special Issue HPV Vaccinations: Coverage, Challenges, and Strategies)
  • Article
  • Open Access
683 Views
18 Pages

Duration of the Humoral Immune Response to Influenza Vaccination in a Cohort of Repeatedly Vaccinated Adults over Four Consecutive Epidemic Seasons: 2018/19–2021/22 Observational Study

  • Mariia V. Sergeeva,
  • Polina Kudar,
  • Yulia Desheva,
  • Ekaterina Romanovskaya-Romanko and ,
  • Vera Krivitskaya,
  • Janna Buzitskaya,
  • Marina A. Stukova,
  • Irina Kiseleva and
  • Dmitry Lioznov
  • + 4 authors+ 0 author

11 September 2026

Background/Objectives: The impact of repeated annual influenza vaccination on long-term immunogenicity and protection remains debated. Although reduced fold-increases in antibody titers are often observed in repeatedly vaccinated individuals, the eff...

(This article belongs to the Special Issue Vaccine Development for Influenza Virus: 2nd Edition)
  • Review
  • Open Access
798 Views
23 Pages

Vaccine-Associated Enhanced Respiratory Disease: From Animal Models to Human Health

  • Jacob A. Dillard,
  • Reina A. Saldivar,
  • Mark T. Heise and
  • Victoria K. Baxter

10 September 2026

Vaccines are a safe and highly effective tool for protecting both humans and animals against infectious diseases. Although vaccines currently in use in humans have robust safety records, historical examples show that some vaccines have resulted in ad...

(This article belongs to the Special Issue Advancements in Vaccine Research: Epidemiology, Immunogenicity, Effectiveness and Safety)
  • Article
  • Open Access
573 Views
20 Pages

10 September 2026

Background: The continued emergence of antimicrobial-resistant Neisseria gonorrhoeae highlights the urgent need for an effective vaccine. We evaluated the immunogenicity and vaccine potential of six new gonococcal conserved hypothetical proteins iden...

(This article belongs to the Special Issue Challenges to Developing New Vaccines and Improving Existing Platforms)
  • Article
  • Open Access
534 Views
25 Pages

10 September 2026

Background: Glioblastoma (GBM) is a primary malignant tumor of the central nervous system and has a high lethal rate despite therapeutic advances. Although immunotherapies have achieved great success in solid tumors, the highly immunosuppressive tumo...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Review
  • Open Access
558 Views
20 Pages

A Population-Based HIV Vaccine Efficacy Trial Design: Statistical Framework and Design Considerations

  • Holly Janes,
  • Fei Gao,
  • Susan Buchbinder,
  • Charles S. Wiysonge and ,
  • Kimberly Louis,
  • Blossom Napoleon,
  • Amelia Mfiki,
  • Derrick Mapp and
  • Glenda Gray
  • + 4 authors+ 0 author

9 September 2026

An HIV vaccine will be a critical tool for ending the epidemic, yet the next vaccine efficacy trial is likely five or more years away as the field focuses on the early-phase evaluation and optimization of vaccines that induce broadly neutralizing ant...

(This article belongs to the Special Issue The Need for an HIV Vaccine in the Era of Highly Effective PrEP)
  • Article
  • Open Access
424 Views
16 Pages

9 September 2026

Background/Objectives: Vaccine hesitancy remains a significant public health challenge in Japan, particularly following the HPV vaccine suspension (2013–2022) that severely damaged vaccination trust. Although prior studies have linked individua...

(This article belongs to the Collection COVID-19 Vaccine Hesitancy: Correlates and Interventions)
  • Article
  • Open Access
469 Views
22 Pages

9 September 2026

Background/Objectives: Therapeutic cancer vaccination requires innate sensing, antigen presentation, lymphocyte priming, tumor access, cytotoxicity, and persistence. Prophylactic studies cannot demonstrate these antitumor functions but can compare sy...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Article
  • Open Access
518 Views
15 Pages

9 September 2026

Background/Objectives: Respiratory pathogens such as influenza virus and SARS-CoV-2 pose major threats to global public health. Current vaccines provide limited mucosal protection against respiratory infection, while vaccine-induced immunity can wane...

(This article belongs to the Special Issue Mucosal Immunity and Vaccine)
  • Review
  • Open Access
847 Views
42 Pages

Insights into Microbiota–Vaccine Crosstalk in Humans: Mechanisms, Modulators, and Translational Horizons

  • Ahmad R. Shakri,
  • Sidharth P. Mishra,
  • Sarina Lawless,
  • Saswati Pani and ,
  • Priyanka Mishra,
  • Courtney L. Page,
  • Gaurav Dutta and
  • Chanchal Sharma
  • + 3 authors+ 0 author

9 September 2026

Vaccine responses differ substantially among individuals and across populations. Although factors such as age, genetics, and vaccine type are recognized contributors, they do not fully explain this heterogeneity. Emerging evidence suggests that the h...

(This article belongs to the Special Issue Novel Vaccine Designs to Enhance the Engagement of Innate and Adaptive Immunity)
  • Article
  • Open Access
733 Views
14 Pages

Real-World Utilization of the Novavax Adjuvanted Recombinant Protein COVID-19 Vaccine in France During the 2022–2024 Period

  • Stephanie H. Read,
  • Lucie Kutikova,
  • Gaelle Gusto,
  • Raissa Kapnang and ,
  • Nadia Quignot,
  • Artak Khachatryan,
  • Clotilde El Guerche-Séblain,
  • Vincent Petit,
  • Jonathan Fix and
  • Odile Launay
  • + 7 authors+ 2 authors

9 September 2026

Background/Objectives: The Novavax COVID-19 vaccine (Nuvaxovid™) was authorized in France in December 2021, assisting in ending the global pandemic and providing an alternative to other COVID-19 vaccines. Understanding Nuvaxovid recipients&rsqu...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Review
  • Open Access
728 Views
20 Pages

9 September 2026

Vaccines that elicit durable immune responses require efficient delivery of antigen to antigen-presenting cells (APCs), in combination with appropriate contextual signals that promote immunity. Recombinant antibody vaccines are a flexible platform fo...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
482 Views
16 Pages

Characterization of Seasonal Trivalent Influenza Vaccine Formulated with Different Ratios (v/v) of Squalene-Containing IB160 Adjuvant in One- or Two-Vial Presentations

  • Daniela Cajado-Carvalho,
  • Paulo Newton Tonolli,
  • Verônica de Moraes Manzato,
  • Lívia Mendonça Munhoz Dati and ,
  • Mahyumi Fujimori,
  • Patrícia Antonia Estima Abreu,
  • Christian Savio Silva,
  • Vitor Anselmo Sakihara,
  • Bianca Pereira Carvalho Holanda and
  • Paulo Lee Ho
  • + 11 authors+ 6 authors

9 September 2026

Background/Objectives: Adjuvanted influenza vaccines are critical to enhance immune responses in high-risk populations, such as the elderly. While initial studies relied on a two-vial system with antigen and adjuvant mixing prior to immunization, thi...

(This article belongs to the Special Issue Vaccine Development for Influenza Virus: 2nd Edition)
  • Article
  • Open Access
403 Views
17 Pages

8 September 2026

Background/Objectives: This study evaluated changes in routine adult vaccination across the COVID-19 pandemic period in Istanbul primary care using interrupted time series (ITS) analysis, disentangling immediate from gradual effects and comparing pat...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)

of 3

XFacebookLinkedIn
Vaccines - ISSN 2076-393X